Literature DB >> 1934241

Economic analysis of several types of malaria clinics in Thailand.

M B Ettling1, K Thimasarn, D S Shepard, S Krachaiklin.   

Abstract

The costs of three types of malaria clinics in Maesot District, north-west Thailand, for a one-year period in 1985-86 were compared from the institutional, community and social (institutional plus community) perspectives. The greatest number of patients at the lowest average institutional cost per smear and per positive case diagnosed (US$ 0.82) were seen at the large central clinic in Maesot town. The peripheral clinic in Popphra, a subdistrict town, had moderate institutional costs per smear and per positive case (US$ 1.58). The periodic mobile clinic, which served five villages on a fixed weekly schedule, had low average institutional costs per smear, but the highest cost per positive case (US$ 3.53). Community costs (those paid by patients and their families) were lowest in the periodic clinic. Addition of a periodic clinic to a system of central and peripheral clinics increased the number of malaria cases treated, particularly those involving women and under-16-year-olds. Although the periodic clinic entailed a modest increase in institutional costs, it minimized social costs. The results of the study suggest that use of a combination of central, peripheral, and periodic clinics, which maximizes access to malaria treatment, minimizes the social costs of malaria.

Entities:  

Keywords:  Asia; Comparative Studies; Cost Benefit Analysis; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Economic Factors; Evaluation; Examinations And Diagnoses; Health; Health Facilities; Laboratory Examinations And Diagnoses; Laboratory Procedures; Malaria; Parasitic Diseases; Population; Population Characteristics; Quantitative Evaluation; Research Methodology; Rural Population; Socioeconomic Factors; Southeastern Asia; Studies; Thailand

Mesh:

Year:  1991        PMID: 1934241      PMCID: PMC2393229     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81.

Authors:  S Pinichpongse; E B Doberstyn; J R Cullen; L Yisunsri; Y Thongsombun; K Thimasarn
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

2.  Malaria clinics in Mae Sot, Thailand: factors affecting clinic attendance.

Authors:  M B Ettling; K Thimasarn; S Krachaiklin; P Bualombai
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-09       Impact factor: 0.267

3.  The Thai expanded programme on immunization: role of immunization sessions and their cost-effectiveness.

Authors:  K Phonboon; D S Shepard; S Ramaboot; P Kunasol; S Preuksaraj
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

4.  Evaluation of malaria clinics in Maesot, Thailand: use of serology to assess coverage.

Authors:  M B Ettling; K Thimasarn; S Krachaiklin; P Bualombai
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

  4 in total
  5 in total

1.  Determinants of household direct and indirect costs: an insight for health-seeking behaviour in Burkina Faso.

Authors:  Tin Tin Su; Steffen Flessa
Journal:  Eur J Health Econ       Date:  2011-09-28

2.  Economic implications of resistance to antimalarial drugs.

Authors:  M Phillips; P A Phillips-Howard
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

3.  Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand.

Authors:  W Fungladda; E R Honrado; K Thimasarn; D Kitayaporn; J Karbwang; P Kamolratanakul; R Masngammueng
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

4.  Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base.

Authors:  Jo-Ann Mulligan; Damian Walker; Julia Fox-Rushby
Journal:  Cost Eff Resour Alloc       Date:  2006-04-03

5.  Cost of increasing access to artemisinin combination therapy: the Cambodian experience.

Authors:  Shunmay Yeung; Wim Van Damme; Duong Socheat; Nicholas J White; Anne Mills
Journal:  Malar J       Date:  2008-05-20       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.